What's Happening?
Paul Bennett, the chief executive of the Royal Pharmaceutical Society (RPS), will step down in April 2026 after overseeing the Society's transition to a royal college. Bennett has led the RPS since 2017 and will continue to guide the organization through this significant change. The transition involves registering as a charity and restructuring the leadership team, including appointing Karen Baxter as interim chief executive. The move to become a royal college was supported by 71.1% of RPS members in a recent vote.
AD
Why It's Important?
The transition to a royal college marks a pivotal moment for the RPS, aiming to enhance its role in the pharmacy profession. The restructuring will focus on strengthening the organization's financial and technological foundations, ensuring it can effectively support its members and advance its strategic goals. The change is expected to bring new opportunities for collaboration and professional development within the pharmacy sector.
What's Next?
The RPS will recruit new leadership roles to support the transition, including a chair of trustees and directors for finance, pharmacy, and education. The organization will focus on establishing a strong foundation for the Royal College of Pharmacy, aiming to deliver effective professional leadership and support for its members.
